These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 23011889)

  • 1. Synergistic induction of apoptosis and chemosensitization of human colorectal cancer cells by histone deacetylase inhibitor, scriptaid, and proteasome inhibitors: potential mechanisms of action.
    Abaza MS; Bahman AM; Al-Attiyah RJ; Kollamparambil AM
    Tumour Biol; 2012 Dec; 33(6):1951-72. PubMed ID: 23011889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superior antimitogenic and chemosensitization activities of the combination treatment of the histone deacetylase inhibitor apicidin and proteasome inhibitors on human colorectal cancer cells.
    Abaza MS; Bahman AM; Al-Attiyah R
    Int J Oncol; 2014 Jan; 44(1):105-28. PubMed ID: 24146045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valproic acid, an anti-epileptic drug and a histone deacetylase inhibitor, in combination with proteasome inhibitors exerts antiproliferative, pro-apoptotic and chemosensitizing effects in human colorectal cancer cells: underlying molecular mechanisms.
    Abaza MS; Bahman AM; Al-Attiyah RJ
    Int J Mol Med; 2014 Aug; 34(2):513-32. PubMed ID: 24899129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin synergistically enhances antitumor activity of histone deacetylase inhibitor trichostatin a against osteosarcoma cell line.
    Duo J; Ma Y; Wang G; Han X; Zhang C
    DNA Cell Biol; 2013 Apr; 32(4):156-64. PubMed ID: 23451817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scriptaid effects on breast cancer cell lines.
    Giacinti L; Giacinti C; Gabellini C; Rizzuto E; Lopez M; Giordano A
    J Cell Physiol; 2012 Oct; 227(10):3426-33. PubMed ID: 22213035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
    Takai N; Ueda T; Nishida M; Nasu K; Narahara H
    Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCI-24781 induces caspase and reactive oxygen species-dependent apoptosis through NF-kappaB mechanisms and is synergistic with bortezomib in lymphoma cells.
    Bhalla S; Balasubramanian S; David K; Sirisawad M; Buggy J; Mauro L; Prachand S; Miller R; Gordon LI; Evens AM
    Clin Cancer Res; 2009 May; 15(10):3354-65. PubMed ID: 19417023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells.
    Lee EJ; Lee BB; Kim SJ; Park YD; Park J; Kim DH
    Int J Oncol; 2008 Oct; 33(4):767-76. PubMed ID: 18813790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anticancer effect of histone deacetylase inhibitor scriptaid as a single agent for hepatocellular carcinoma.
    Liu L; Sun X; Xie Y; Zhuang Y; Yao R; Xu K
    Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29945926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simultaneous NF-κB inhibition and E-cadherin upregulation mediate mutually synergistic anticancer activity of celastrol and SAHA in vitro and in vivo.
    Zheng L; Fu Y; Zhuang L; Gai R; Ma J; Lou J; Zhu H; He Q; Yang B
    Int J Cancer; 2014 Oct; 135(7):1721-32. PubMed ID: 24615207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic interaction of the histone deacetylase inhibitor SAHA with the proteasome inhibitor bortezomib in mantle cell lymphoma.
    Heider U; von Metzler I; Kaiser M; Rosche M; Sterz J; Rötzer S; Rademacher J; Jakob C; Fleissner C; Kuckelkorn U; Kloetzel PM; Sezer O
    Eur J Haematol; 2008 Feb; 80(2):133-42. PubMed ID: 18005386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol sensitizes acute myelogenous leukemia cells to histone deacetylase inhibitors through reactive oxygen species-mediated activation of the extrinsic apoptotic pathway.
    Yaseen A; Chen S; Hock S; Rosato R; Dent P; Dai Y; Grant S
    Mol Pharmacol; 2012 Dec; 82(6):1030-41. PubMed ID: 22923501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Scriptaid cause histone deacetylase inhibition and cell cycle arrest in HeLa cancer cells: A study on structural and functional aspects.
    Janaki Ramaiah M; Naushad SM; Lavanya A; Srinivas C; Anjana Devi T; Sampathkumar S; Dharan DB; Bhadra MP
    Gene; 2017 Sep; 627():379-386. PubMed ID: 28668345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity.
    Sharma V; Koul N; Joseph C; Dixit D; Ghosh S; Sen E
    J Cell Mol Med; 2010 Aug; 14(8):2151-61. PubMed ID: 19583803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of pancreatic cancer cells by histone deacetylase inhibitor belinostat through suppression of multiple pathways including HIF, NFkB, and mTOR signaling in vitro and in vivo.
    Chien W; Lee DH; Zheng Y; Wuensche P; Alvarez R; Wen DL; Aribi AM; Thean SM; Doan NB; Said JW; Koeffler HP
    Mol Carcinog; 2014 Sep; 53(9):722-35. PubMed ID: 23475695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
    Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
    Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic antitumor effects of histone deacetylase inhibitor scriptaid and bortezomib against ovarian cancer cells.
    Janyst K; Janyst M; Siernicka M; Lasek W
    Oncol Rep; 2018 Apr; 39(4):1999-2005. PubMed ID: 29436692
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation.
    Borbone E; Berlingieri MT; De Bellis F; Nebbioso A; Chiappetta G; Mai A; Altucci L; Fusco A
    Oncogene; 2010 Jan; 29(1):105-16. PubMed ID: 19802013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inactivation of NF-kappaB by proteasome inhibition contributes to increased apoptosis induced by histone deacetylase inhibitors in human breast cancer cells.
    Domingo-Domènech J; Pippa R; Tápia M; Gascón P; Bachs O; Bosch M
    Breast Cancer Res Treat; 2008 Nov; 112(1):53-62. PubMed ID: 18064564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.